CYCN
NASDAQ
$3.61
Cyclerion Therapeutics Inc (CYCN)
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development, and commercialization of drugs for serious diseases of the central nervous system (CNS). The company is headquartered in Cambridge, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Target: $8 (+121.61%)
Market Cap
$16M
Free Cash Flow Yield
-22.80%
Beta (5Y)
0.82
Price Chart
Valuation
Market Cap$16M
P/S8.06
P/B2.44
Profitability
Total Revenue (TTM)$1.99M
Gross Profit (TTM)$340K
EBITDA-$5.28M
Profit Margin-77.9%
Operating Margin-81.8%
EPS-$1.33
Financial Health
Free Cash Flow Yield-22.80%
Growth & Risk
EPS 5Y CAGR-49.51%
Revenue 5Y CAGR+8.20%
FCF 5Y CAGR-42.66%
Beta (5Y)0.82
Sharpe Ratio0.72